CEO of Cambridge Cognition to speak at 2013 SharpBrains Summit

By SharpBrains | June 14, 2013

Ruth Frances Keir runs Cam­bridge Cog­ni­tion (AIM: COG), one of the 10 Com­pa­nies to Watch in 2013/ 2014 accord­ing to our lat­est mar­ket report, which devel­ops and com­mer­cial­izes com­put­erised neu­ropsy­cho­log­i­cal tests used in a vari­ety of health­care and research set­tings. She joined the Cam­bridge Cog­ni­tion board ini­tial­ly in 2010 as a non-exec­u­­tive direc­tor, bring­ing to it more…

Read More

Measuring and treating Chemo Brain

By SharpBrains | October 3, 2012

‘Chemo Brain’ After Breast Can­cer Backed by Study (US News): “Breast can­cer patients treat­ed with chemother­a­py are at risk for mild men­tal deficits known col­lec­tive­ly as “chemo brain,” a new study finds. Researchers at the Mof­fitt Can­cer Cen­ter in Tam­pa, Fla., reviewed exist­ing research on brain func­tion (“cog­ni­tive” func­tion­ing) in

Read More

Cognitive Enhancement via Pharmacology AND Neuropsychology, in The New Executive Brain

By Alvaro Fernandez | August 30, 2009

(Edi­tor’s Note: giv­en the grow­ing media atten­tion to three appar­ent­ly sep­a­rate worlds ‑cog­ni­tive enhance­ment via drugs, brain fit­ness train­ing soft­ware, com­put­er­ized neu­rocog­ni­tive assessments‑, I found it refresh­ing to see our co-founder Elkhonon Gold­berg intro­duce the top­ic of cog­notrop­ic drugs with an inte­gra­tive per­spec­tive in the much updat­ed new edi­tion of his clas­sic book, now titled…

Read More

Why computerized neuropsychological tests will become routine — chemo brain example

By Alvaro Fernandez | August 4, 2009

Good arti­cle today in the NYT on “chemo brain” — some typ­i­cal short-term and long-term cog­ni­tive con­se­quences of chemother­a­py. The Fog That Fol­lows Chemother­a­py (New York Times) This quote is crit­i­cal — for chemo brain and also for a vari­ety of clin­i­cal con­di­tions that present asso­ci­at­ed cog­ni­tive impair­ments: “Con­trol­ling for brain func­tion before can­cer treat­ment begins…

Read More